CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation (NCT07008911)
CardioHeartConnect: Commercially Available Fitness mHealth for Cardiac Rehabilitation Among Individuals Recovering From Transcatheter Aortic Valve Replacement
🩺 Plain-English Summary (8th-Grade Level)
This trial evaluates the effectiveness of CardioHeartConnect, an eight-week mobile cardiac rehabilitation intervention using Peloton fitness modules, compared to educational control among patients recovering from transcatheter aortic valve replacement (TAVR). The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health using wearable devices and a digital engagement platform. A total of 200 patients will be recruited from the UCHealth Structural Heart and Valve Clinic and randomized to either CardioHeartConnect or CardioHeartEd. Participants will be assessed at baseline, 8 weeks, and 12 months using surveys, smartwatch data, and electronic health records.
Who can join: Review the eligibility criteria below.
Location: UCHealth Structural Heart and Valve Clinic — Aurora, Colorado
Age range: 18 Years
🧪 Interventions in This Study
- CardioHeartConnect (BEHAVIORAL)
- CardioHeartEd (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UCHealth Structural Heart and Valve Clinic — Aurora, Colorado
📞 Contact the Study Coordinator
Phone: (303) 724-1889
Email: joshua.rosen@cuanschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Valve Stenosis
- ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis — Los Angeles, California
- Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation — Québec, Quebec
- Inspiris Resilia Durability Registry — Sankt Pölten,
- Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Chandler, Arizona
- Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Phoenix, Arizona
- Platelet Adhesion in the Pathobiology of Aortic Stenosis — Charlottesville, Virginia
Explore by condition: All Aortic Valve Stenosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.